Integra LifeSciences Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Integra LifeSciences (IART) Reports In-Line Q2 EPS; Tightens FY Rev Range
July 26, 2017 6:05 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.45, in-line with the analyst estimate of $0.45. Revenue for the quarter came in at $282.2 million versus the consensus estimate of $283.7 million.
The company is tightening full-year 2017 revenue guidance to a new range of $1.125 billion to $1.140 billion,... More